Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patients

Although a glucocorticoid (GC)-sparing strategy is needed for patients with giant cell arteritis (GCA) suffering from refractory disease or serious treatment-related complications, evidence of efficacy in this setting of immunosuppressive drugs and biotherapies is lacking. Herein, we evaluated the G...

Descripción completa

Detalles Bibliográficos
Autores principales: Ly, Kim Heang, Dalmay, François, Gondran, Guillaume, Palat, Sylvain, Bezanahary, Holy, Cypierre, Anne, Fauchais, Anne-Laure, Liozon, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079312/
https://www.ncbi.nlm.nih.gov/pubmed/27759628
http://dx.doi.org/10.1097/MD.0000000000004974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079312/
https://www.ncbi.nlm.nih.gov/pubmed/27759628
http://dx.doi.org/10.1097/MD.0000000000004974

Ejemplares similares